News >

NCI Director Ned Sharpless to Be Named Acting FDA Commissioner

Kristi Rosa
Published: Tuesday, Mar 12, 2019

Norman (Ned) E. Sharpless, MD

Norman (Ned) E. Sharpless, MD

National Cancer Institute (NCI) director Norman (Ned) E. Sharpless, MD, has been named as acting commissioner of the FDA once Scott Gottlieb, MD, leaves the regulatory agency in April 2019, according to an announcement by the Health and Human Services Secretary (HSS).1



  1. Ned Sharpless, director of the National Cancer Institute, to be named acting FDA commissioner [news release]. Washington, DC: Stat News; Published March 12, 2019. Accessed March 12, 2019.
  2. NCI director Dr. Norman E. Sharpless. National Cancer Institute. Updated March 11, 2019. Accessed March 12, 2019.
  3. Sharpless Tapped as NCI Director. OncLive. Published June 12, 2017. Accessed March 12, 2019.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication